Diabetes, Vol 46, Issue 1 28-33, Copyright © 1997 by American Diabetes Association

ARTICLES

The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined

V Gupta, DC Wahoff, DP Rooney, V Poitout, DE Sutherland, DM Kendall and RP Robertson
Department of Medicine, University of Minnesota Medical School, Minneapolis 55455, USA.

The optimal site for pancreatic islet cell transplantation is presently unclear, although the liver has been the most commonly used. However, glucagon secretion from islets that have been autotransplanted in liver has been reported to be unresponsive to hypoglycemia yet responsive to arginine. To determine whether this selective glucagon secretory defect is related to the intrahepatic site of islet implantation or to the process of transplantation per se, we studied counterregulatory responses to hypoglycemia in dogs with pancreatic islet autotransplantation in the hepatic parenchyma (the intrahepatic [IH] group, n = 9) or the peritoneal cavity (the intraperitoneal [IP] group, n = 9), following total pancreatectomy, and compared them with the responses in normal controls (n = 10). Dogs were subjected to a hypoglycemic hyperinsulinemic (5 mU x kg-1 x min-1) clamp for 90 min under general anesthesia. Arterial glucose concentrations were clamped at 2.7 mmol/l for the final 45 min of the clamp. Immediately following the clamp, glucagon responses to IV arginine (5 g) were also assessed. During hypoglycemia, glucagon responses in the IH group (maximal incremental glucagon = 33 +/- 21 ng/l; glucagon area under curve [AUC] = 713 +/- 1,022 ng x l-1 x min-1) were significantly lower than either the IP (maximal incremental glucagon = 92 +/- 32 ng/l; glucagon AUC = 4,090 +/- 1,600 ng x l-1 x min-1) or control (maximal incremental glucagon = 154 +/- 71 ng/l; glucagon AUC = 6,943 +/- 2,842 ng x l-1 x min-1) group (IH vs. IP group, P < 0.05; control vs. IH group, P < 0.01). Glucagon responses in the IP group did not differ significantly from the control group. Epinephrine responses to hypoglycemia were similar in all groups, whereas neither of the transplanted groups (IH and IP) had pancreatic polypeptide responses. There was a prompt rise in plasma glucagon after intravenous arginine in all groups. These data indicate that glucagon unresponsiveness to hypoglycemia is specific to intrahepatically transplanted islets, rendering the liver a disadvantageous site for optimal alpha-cell function.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. Zhou, T. Zhang, M. Bogdani, E. Oseid, S. Parazzoli, M.-C. Vantyghem, J. Harmon, M. Slucca, and R. P. Robertson Intrahepatic Glucose Flux as a Mechanism for Defective Intrahepatic Islet {alpha}-Cell Response to Hypoglycemia Diabetes, June 1, 2008; 57(6): 1567 - 1574. [Abstract] [Full Text] [PDF]

				J. Lau, G. Mattsson, C. Carlsson, D. Nyqvist, M. Kohler, P.-O. Berggren, L. Jansson, and P.-O. Carlsson Implantation Site-Dependent Dysfunction of Transplanted Pancreatic Islets Diabetes, June 1, 2007; 56(6): 1544 - 1550. [Abstract] [Full Text] [PDF]

				J. Gromada, I. Franklin, and C. B. Wollheim {alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains Endocr. Rev., February 1, 2007; 28(1): 84 - 116. [Abstract] [Full Text] [PDF]

				M. R. Rickels, M. H. Schutta, R. Mueller, J. F. Markmann, C. F. Barker, A. Naji, and K. L. Teff Islet Cell Hormonal Responses to Hypoglycemia After Human Islet Transplantation for Type 1 Diabetes Diabetes, November 1, 2005; 54(11): 3205 - 3211. [Abstract] [Full Text] [PDF]

				E. A. Ryan, B. W. Paty, P. A. Senior, D. Bigam, E. Alfadhli, N. M. Kneteman, J. R.T. Lakey, and A.M. J. Shapiro Five-Year Follow-Up After Clinical Islet Transplantation Diabetes, July 1, 2005; 54(7): 2060 - 2069. [Abstract] [Full Text] [PDF]

				J. L. Larsen Pancreas Transplantation: Indications and Consequences Endocr. Rev., December 1, 2004; 25(6): 919 - 946. [Abstract] [Full Text] [PDF]

				G. Mattsson, L. Jansson, A. Nordin, A. Andersson, and P.-O. Carlsson Evidence of Functional Impairment of Syngeneically Transplanted Mouse Pancreatic Islets Retrieved from the Liver Diabetes, April 1, 2004; 53(4): 948 - 954. [Abstract] [Full Text] [PDF]

				R. P. Robertson Islet Transplantation as a Treatment for Diabetes -- A Work in Progress N. Engl. J. Med., February 12, 2004; 350(7): 694 - 705. [Full Text] [PDF]

				R. P. Robertson Intrahepatically Transplanted Islets--Strangers in a Strange Land J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5416 - 5417. [Full Text] [PDF]

				B. W. Paty, E. A. Ryan, A.M. J. Shapiro, J. R.T. Lakey, and R. P. Robertson Intrahepatic Islet Transplantation in Type 1 Diabetic Patients Does Not Restore Hypoglycemic Hormonal Counterregulation or Symptom Recognition After Insulin Independence Diabetes, December 1, 2002; 51(12): 3428 - 3434. [Abstract] [Full Text] [PDF]

				C. Semakula, S. Pambuccian, R. Gruessner, D. Kendall, G. Pittenger, A. Vinik, and E. R. Seaquist Hypoglycemia after Pancreas Transplantation: Association with Allograft Nesidiodysplasia and Expression of Islet Neogenesis-Associated Peptide J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3548 - 3554. [Abstract] [Full Text] [PDF]

				S. M. Sherck, M. Shiota, J. Saccomando, S. Cardin, E. J. Allen, J. R. Hastings, D. W. Neal, P. E. Williams, and A. D. Cherrington Pancreatic Response to Mild Non-Insulin-Induced Hypoglycemia Does Not Involve Extrinsic Neural Input Diabetes, November 1, 2001; 50(11): 2487 - 2496. [Abstract] [Full Text] [PDF]

				P.-O. Carlsson, F. Palm, A. Andersson, and P. Liss Markedly Decreased Oxygen Tension in Transplanted Rat Pancreatic Islets Irrespective of the Implantation Site Diabetes, March 1, 2001; 50(3): 489 - 495. [Abstract] [Full Text]